The deal information has been sourced from an SEC filing published on the SEC EDGAR database on August 6, 2026. The specific form type is not identified in the available documentation. Given the pending regulatory status, the transaction has not yet closed and remains subject to customary conditions and regulatory clearance.
Barclays is serving as the exclusive financial advisor to Tarsus, the acquirer, in a lead capacity on this transaction. On the target side, Jefferies is acting as the exclusive financial advisor to Alkeus, also in a lead advisory role. Both firms are providing comprehensive financial advisory services to their respective clients throughout the deal process.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian, LLP is providing legal counsel to Tarsus in connection with the acquisition. Latham & Watkins LLP is serving as legal counsel to Alkeus, the target company. Both firms are handling all legal matters related to the transaction for their respective clients.
The transaction is valued at $450 million, though the specific mix of consideration, whether structured as cash, stock, or a combination thereof, has not been disclosed. The deal structure remains undisclosed beyond the headline valuation figure. No information has been provided regarding the relative weighting between cash and equity consideration, any earnout provisions, closing conditions beyond regulatory approval, timing for regulatory review, or an expected closing date. The target company Alkeus' sector classification and operational details have not been specified. Additionally, the specific regulatory agencies with jurisdiction over this transaction and their anticipated approval timelines have not been disclosed.